Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial

Clinical trial NCT02664181 · COMPLETED

Trial details

NCT number: NCT02664181
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-small Cell Lung Cancer

Start date: 2017-06-06
Primary completion: 2019-07-02
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.